Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARWR | CPRX | NAMS | ||
| Company | Arrowhead Pharma | Catalyst Pharm Inc | Newamsterdam Pharma Company N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 21.12 | 21.51 | 25.00 | ||
| High | 21.25 | 21.63 | 25.16 | ||
| Low | 18.54 | 20.44 | 24.50 | ||
| Last | 18.57 | 20.60 | 24.90 | ||
| Change | -2.84 | -1.09 | -0.07 | ||
| % Change | -13.26% | -5.03% | -0.28% | ||
| Volume | 1,908,800 | 1,708,500 | 891,900 | ||
| 20-Day Average Volume | 997,215 | 1,025,155 | 419,640 | ||
| Previous Close | 21.41 | 21.69 | 24.97 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 20.49 | 22.04 | 20.78 | ||
| 20-Day Raw Stochastic | 0.76% | 4.18% | 96.99% | ||
| 20-Day Relative Strength | 39.17% | 44.67% | 75.50% | ||
| Weighted Alpha | -38.93 | +48.41 | +85.32 | ||
| Today's Opinion | 80% Sell | 64% Buy | 56% Buy | ||
| Previous Opinion | 40% Sell | 88% Buy | 56% Buy | ||
| Last Month's Opinion | 80% Sell | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -15.17% since 11/08/24 | -13.92% since 11/08/24 | +3.23% since 11/08/24 | ||
| Low | 18.54 on 11/15/24 | 20.44 on 11/15/24 | 23.91 on 11/11/24 | ||
| High | 22.51 on 11/11/24 | 24.11 on 11/11/24 | 25.16 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -6.59% since 10/15/24 | -2.74% since 10/15/24 | +31.05% since 10/15/24 | ||
| Low | 18.54 on 11/15/24 | 20.44 on 11/15/24 | 16.51 on 11/01/24 | ||
| High | 22.51 on 11/11/24 | 24.27 on 11/08/24 | 25.16 on 11/15/24 | ||
| 3-Month | |||||
| %Chg | -18.05% since 08/15/24 | +3.47% since 08/15/24 | +51.92% since 08/15/24 | ||
| Low | 17.05 on 10/10/24 | 19.00 on 09/11/24 | 15.19 on 09/25/24 | ||
| High | 25.38 on 08/22/24 | 24.27 on 11/08/24 | 25.16 on 11/15/24 | ||
| 6-Month | |||||
| %Chg | -25.84% since 05/15/24 | +23.65% since 05/15/24 | +25.69% since 05/15/24 | ||
| Low | 17.05 on 10/10/24 | 14.75 on 06/26/24 | 15.19 on 09/25/24 | ||
| High | 30.41 on 07/16/24 | 24.27 on 11/08/24 | 25.16 on 11/15/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,308,530 | 2,457,024 | 2,241,373 | ||
| Shares Outstanding, K | 124,315 | 119,273 | 90,015 | ||
| Annual Sales | 240,740,000 | 398,200,000 | 14,090,000 | ||
| Annual Net Income | -205,280,000 | 71,410,000 | -176,940,000 | ||
| Last Quarter Sales | 0 | 128,700,000 | 29,110,000 | ||
| Last Quarter Net Income | -125,300,000 | 43,880,000 | -16,650,000 | ||
| 60-Month Beta | 0.93 | 0.75 | -0.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.38 on 08/08/24 | 0.57 on 11/06/24 | -0.18 on 11/06/24 | ||
| Latest Earnings Date | 11/26/24 | 11/06/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.72 | 0.00 | ||